NCT07709819 A Nanoscopic Second Look Into the Knee Joint
| NCT ID | NCT07709819 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Angelina Vera MD |
| Condition | Meniscal Tears |
| Study Type | INTERVENTIONAL |
| Enrollment | 15 participants |
| Start Date | 2026-05-20 |
| Primary Completion | 2028-05-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 15 participants in total. It began in 2026-05-20 with a primary completion date of 2028-05-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to look at how well different surgeries heal over time in patients that have previously undergone arthroscopic knee interventions. These procedures may include cartilage repair or grafting, meniscus repair or trimming, ligament reconstruction, cartilage smoothing, and treatments such as amniotic tissue or platelet rich plasma (PRP). Using a very small camera called a nanoarthroscope, doctors will take a "second look" inside the knee after surgery to see how it has healed. These findings will be compared to patient-reported outcomes, such as pain and function scores, as well as images taken during the original surgery. The goal is to determine whether this second look provides useful information that can help guide recovery and future care.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 years and older who have undergone or are scheduled to undergo arthroscopic knee intervention. * Eligible procedures include meniscus repair, biocartilage procedures, and other arthroscopic biologic interventions of the knee * Ability to understand and provide informed consent * Agreement to undergo postoperative in-clinic second-look nanoscopic arthroscopy of the knee. Exclusion Criteria: * Refusal to undergo postoperative in-clinic second-look nanoscopic arthroscopy of the knee. * Inability to provide informed consent. * Individuals who are not yet adults (infants, children, teenagers). * Pregnant women * Prisoners
Contact & Investigator
Angelina Vera, MD, FAAOS, FAANA
PRINCIPAL INVESTIGATOR
University Medical Center of Southern Nevada
Frequently Asked Questions
Who can join the NCT07709819 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Meniscal Tears. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07709819 currently recruiting?
Yes, NCT07709819 is actively recruiting participants. Contact the research team at robert.panganiban@umcsn.com for enrollment information.
Where is the NCT07709819 trial being conducted?
This trial is being conducted at Las Vegas, United States.
Who is sponsoring the NCT07709819 clinical trial?
NCT07709819 is sponsored by Angelina Vera MD. The principal investigator is Angelina Vera, MD, FAAOS, FAANA at University Medical Center of Southern Nevada. The trial plans to enroll 15 participants.